Clinical Trial Results: Clinical Study to Assess the Efficacy of Once-daily IMM-124E (Travelan®) in a Controlled Human Infection Model. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating once-daily IMM-124E (Travelan) for efficacy in a controlled human infection model in travelers with diarrhea conditions; study complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diarrhea
• Infectious Diarrhea
• Traveler Diarrhea

Drugs mentioned

• IMM-124E (Travelan) (IMM-124E)

Snippet

Sponsor: Immuron Ltd. | Conditions: Diarrhea, Travelers Diarrhea | Phase 2 | Status: COMPLETED | Results posted: 2026-06-12